Thomas Marchand, President & CEO at NIDO || LSI 2021 Emerging Medtech Summit скачать в хорошем качестве

Thomas Marchand, President & CEO at NIDO || LSI 2021 Emerging Medtech Summit

Thomas Marchand, President & CEO at NIDO was a presenter at the #LSI2021 Emerging Medtech Summit, where they were featured to an audience of active investors and strategic partners. NIDO (Boston, MA) is a medical device company developing SEPIA, an innovative solution for epicardial ablation of ventricular tachycardia (VT), based on technology developed at Boston Children's Hospital. It has been co-founded by Pedro del Nido, Chairman of Cardiovascular Surgery and Professor at Harvard Medical School, and Nikolay Vasilyev, Medical Director for Surgicals Portfolio at Pfizer. SEPIA will allow real-time visualization of the epicardial surface and provide angle and force control to an ablation catheter. The #LSIUSA22 Emerging Medtech Summit will feature medtech start-ups that are raising capital and seeking strategic partners. This event is scheduled for March 15-18, 2022 at the Waldorf Astoria, Monarch Beach Resort in Dana Point, CA. Details can be found at: https://www.lifesciencemarketresearch...